# AIM ImmunoTech (AIM) — Overview

AIM · AMEX · Stock

Canonical page: https://www.lighthorse.io/tickers/aim

## Price

Last close $0.17 on Oct 15, 2026. 52-week range $0.16 – $2.76.

## Company profile

AIM ImmunoTech Inc is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders, and to treat cancers for which there are currently inadequate or unmet therapies. Its flagship products are Ampligen (rintatolimod) and Alferon N Injection (Interferon alfa). Ampligen is a double-stranded RNA (dsRNA) molecule being developed for globally important cancers, viral diseases, and disorders of the immune system. Ampligen is approved for commercial sale in the Argentine Republic for the treatment of severe Chronic Fatigue Syndrome (CFS).

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $95,000.00 |
| Revenue (quarter) | $26,000.00 |
| Revenue growth (year over year) | 4.00% |
| Gross profit (trailing twelve months) | −$22,000.00 |
| Gross margin | -23.16% |
| Net income (trailing twelve months) | −$14.3M |
| Net income (quarter) | −$3.8M |
| Net income growth (year over year) | -35.58% |
| Net margin | -15021.05% |
| Return on equity | -2382.30% |
| EPS (trailing twelve months) | −$0.70 |
| Book value per share | $0.27 |
| P/E (trailing twelve months) | — |
| Price to book | 0.9 |
| Debt to assets | 39.17% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is AIM ImmunoTech (AIM) profitable?

No. AIM ImmunoTech reported a net loss of $14.3M over the trailing twelve months.

### How much revenue does AIM ImmunoTech (AIM) make?

AIM ImmunoTech generated $95,000.00 in revenue over the trailing twelve months, up 4.00% year over year.

### How do I buy stock in AIM ImmunoTech (AIM)?

AIM trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).